No. | Title | Date | View |
---|---|---|---|
56 |
|
2023-12-01 | 46 |
55 | 2023-11-30 | 114 | |
54 | 2023-06-15 | 817 | |
53 | 2023-06-02 | 677 | |
52 |
OliX Inks MOU with DynamiCure Biotechnology to Develop ADC Immunotherapy Using RNA
|
2023-06-02 | 620 |
51 | 2023-05-09 | 591 | |
50 | 2023-03-28 | 1069 | |
49 | 2023-03-27 | 1080 | |
48 | 2022-11-28 | 1569 | |
47 |
OliX Announces Positive Preclinical Data in NASH Non-human Primate Models
|
2022-11-10 | 958 |
46 |
OliX Receives IND Approval from FDA to Develop RNAi Therapeutic OLX10212 for AMD
|
2022-08-08 | 1556 |
45 | 2022-07-05 | 1502 | |
44 | 2022-07-05 | 1335 | |
43 | 2022-06-13 | 1444 | |
42 | 2022-06-07 | 1745 | |
41 | 2022-05-27 | 2442 | |
40 | 2022-05-27 | 1386 | |
39 | 2022-04-12 | 1968 | |
38 |
OliX Pharmaceuticals to Participate in BIO-Europe Spring®
|
2022-03-24 | 1662 |
37 | 2022-03-22 | 2070 |
- Home
- PR